Background: Arterial blood pressure lability, defined as rapid changes in arterial blood pressure, occurs commonly during anaesthesia. It is believed that hypertensive patients exhibit more lability during surgery and that lability is associated with poorer outcomes. Neither association has been rigorously tested. We hypothesized that hypertensive patients have more blood pressure lability and that increased lability is associated with increased 30 day mortality. Methods: This was a retrospective single-centre study of surgical patients from July 2008 to December 2012. Intraoperative data were extracted from the electronic anaesthesia record. Lability was calculated as the modulus of the percentage change in mean arterial pressure between consecutive 5 min intervals. The number of episodes of lability >10% was tabulated. Multivariate logistic regression was performed to determine the association between lability and 30 day mortality using derivation and validation cohorts. Results: Inclusion criteria were met by 52 919 subjects. Of the derivation cohort, 53% of subjects were hypertensive and 42% used an antihypertensive medication. The median number of episodes of lability >10% was 9 (interquartile range 5-14) per patient. Hypertensive subjects demonstrated more lability than normotensive patients, 10 (5-15) compared with 8 (5-12), P<0.0001. In subjects taking no antihypertensive medication, lability >10% was associated with decreased 30 day mortality, odds ratio (OR) per episode 0.95 [95% confidence interval (CI) 0.92-0.97], P<0.0001. This result was confirmed in the validation cohort, OR 0.96 (95% CI 0.93-0.99), P=0.01, and in hypertensive patients taking no antihypertensive medication, OR 0.96 (95% CI 0.93-0.99), P=0.002. Use of any antihypertensive medication class reduced this effect. Conclusions: Intraoperative arterial blood pressure lability occurs more often in hypertensive patients. Contrary to common belief, increased lability was associated with decreased 30 day mortality.
however, did not investigate associations of lability with outcome. 8 In the present study, we hypothesized that intraoperative haemodynamic lability is associated with an increase in 30 day mortality in patients undergoing non-cardiac surgery. As a secondary outcome, we looked at the incidence of non-fatal perioperative myocardial injury (PMI).
Methods
Institutional Review Board approval and waiver of informed consent were obtained for this study. We retrospectively reviewed all adult (aged 18-89 yr) inpatient and day-of-admission non-cardiac surgical procedures performed at our institution between July 1, 2008 and December 18, 2012. Patients who underwent more than one anaesthetic during their admission were excluded. Haemodynamic data were electronically recorded by our anaesthesia information management system (CompuRecord; Philips Medical, Andover, MA, USA). The frequency of data recording ranged from every 15 s for patients with invasive arterial BP monitoring, to every 1-5 min when non-invasive blood pressure monitoring was used. Patient characteristics, preoperative medication use and perioperative data (e.g. length of surgery, anaesthetic technique, use of blood products) were also obtained from the anaesthesia information management system. Additional data on patient co-morbidities (i.e. ICD-9 diagnosis codes) were retrieved from administrative data. Supplementary data Table S1 provides a detailed description of the definition and source of variables used in the analysis. The 30 day mortality was determined using either institutional administrative data or the Social Security Administration Death Master File (National Technical Information Service, Alexandria, VA, USA).
Assessment of preoperative risk
Preoperative risk was assessed using the ASA physical status score and the Charlson co-morbidity index, which was calculated using ICD-9-CM diagnosis codes, using the methods of Quan and colleagues 9 to map ICD-9-CM codes to co-morbidities and the revised weights of Schneeweiss and colleagues 10 to compute the index (see Supplementary data Table S1 ). The presence of preoperative hypertension was determined using a combination of anaesthesia information management system data (documented hypertension or documentation of antihypertensive medication use) and ICD-9-CM diagnosis codes (see Supplementary data for the definition of ICD-9-CM hypertension codes and full list of antihypertensive medications analysed). Classification of antihypertensive medication was based upon the major classes of antihypertensive medications recommended by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 for the treatment of hypertension (see Supplementary data Table  S2 ). 11 Our goal was to include all medications used to treat hypertension. Preliminary analysis revealed a complex relationship among class of antihypertensive therapy, BP lability, and mortality, with each medication class associated with a distinct level of lability and 30 day mortality (see Supplementary data Table S3 and Fig. S1 ). Antihypertensive medication use was therefore classified as follows: use of no antihypertensive medications, use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) only, use of β-blockers (BB) with or without any other class of antihypertensive medications [ACE/ARBs, calcium channel blockers, diuretics, α 2 -agonists, or directly acting vasodilators], and use of other antihypertensive medications without BB or ACE/ARB (see Supplementary data Fig. S1 ).
To assess the risk of PMI, the revised cardiac risk index (RCRI) was calculated. 12 Perioperative myocardial injury was defined as an abnormal cardiac troponin I within 72 h after surgery. The laboratory cut-off value for an abnormal cardiac troponin I used at our institution during the study period was 0.5 ng ml −1 .
Calculation of intraoperative arterial blood pressure lability
Baseline mean arterial pressure (MAP) was determined by calculating the median of all recorded pre-anaesthesia induction MAP readings. For regional or monitored anaesthesia care (MAC) procedures, block placement or procedure start time, respectively, was used in place of anaesthesia induction time. The degree of intraoperative arterial BP lability was quantified using a previously validated method. 8 Briefly, median MAP was first calculated throughout 5 min intervals throughout the procedure. Medians were used in order to remove monitoring artifacts, such as arterial line flushes, and to minimize the influence of transient changes. 13 Blood pressure lability was then quantified by determining the modulus (absolute value) of the percentage change in MAP between consecutive 5 min intervals. We deliberately did not distinguish between a positive vs a negative change because the parameter of interest was lability, which is a fluctuating value, not dependent on increasing or decreasing values per se. If no valid data were available for a given interval, the last valid MAP was carried forward. In the absence of gold standards for definition of lability, we counted the number of episodes where the lability was within the prespecified ranges 6-10, 11 -15, 16-20, 21-20 , and >25% for each patient. We also counted the number of 5 min intervals during which MAP was within prespecified blood pressure ranges (<50, 50-59, 60-69, 70-79, 80-110, 111-120, 121-130, and >130 mm Hg).
Statistical analysis
Descriptive data are reported as n ( percentage), mean (standard deviation) or median (interquartile range, IQR 
Selection of lability and mean arterial pressure thresholds
In order to determine the most relevant lability thresholds to include in the final model, an initial stepwise logistic regression,
Editor's key points
• In a retrospective analysis of 52 919 subjects undergoing surgery with general anaesthesia, hypertensive subjects had more arterial pressure lability.
• In subjects not taking antihypertensive medication, arterial pressure lability was associated with reduced 30 day mortality.
• These data suggest that labile perioperative haemodynamic responses reflect a more adaptive and protective autonomic nervous system.
with both entry and stay criteria set at 0.05, was used to select the lability ranges most associated with 30 day mortality and PMI. We used ranges instead of thresholds in this initial stepwise regression because the thresholds had a very high degree of collinearity and correlation among themselves. For example, the number of episodes of lability >10% would by definition also include all episodes of lability >20%. Using ranges provided finer discrimination with less overlap. The final model was then constructed by converting ranges into thresholds so as to make the final model inclusive of all ranges more extreme than the ones selected, regardless of statistical significance, because higher ranges tended to show the same direction of effect. For example, if the stepwise regression selected the lability range between 21 and 25% to be significant, the final model would use >20% as the threshold. The same analytic strategy was applied to determine MAP thresholds.
Additional parameters included in the multivariate model 
Assessment of model validity
To assess model validity, the data set was randomly divided into derivation and validation cohorts with a 2:1 ratio. The derivation cohort was used to develop our statistical models for 30 day mortality and PMI, and the validation cohort was then used to test the robustness of the proposed models and their discrimination ability. We performed two sets of validation. First, we performed the conventional approach that applied the β-coefficients from the developed models to the validation data set. Then, using the same set of predictors, we refitted the model to allow the β-coefficients to vary so that we could see whether the proposed predictors remained statistically significant in the validated data set. Goodness of fit for all models was assessed with the Hosmer-Lemeshow test, and the overall adequacy of the models for assessing risk was evaluated by calculating the area under the receiver-operating curve (c-statistic).
In all models, the calculated odds ratio (OR) indicates relative likelihood of mortality per each additional episode of lability or per each additional 5 min of exposure to the BP range considered. The OR is presented as OR [95% confidence interval (CI)], P-value.
The software to calculate and tabulate lability was written in Perl 5.10. Statistical analysis was performed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA) and R 2. Table 1 . There were no clinically meaningful differences between the two cohorts (derivation and validation), despite the statistically significant differences related to the large sample sizes in the following variables: use of BB with or without other medication, use of other antihypertensive medication without BB or ACE/ARB, and percentage of thoracic surgical procedures. Preoperative hypertension was present in 53% of subjects in the derivation cohort, and 42% were taking an antihypertensive medication (Table 1) . The most commonly used antihypertensive medications in the derivation cohort were metoprolol (12%), amlodipine (9%), lisinopril (7%), and hydrochlorothiazide (6%). Supplementary data Table S2 provides a complete listing of all antihypertensive medications used by patients in the entire cohort, stratified by medication class, along with frequency of occurrence.
Almost all subjects (97%) experienced at least one episode of lability >10% [median 9 (5-14)], and a majority (83%) had at least one episode of lability >20% [median 3 (1-5); Fig. 1 ]. Hypertensive subjects had slightly more episodes of lability >10 and >20% per subject than normotensive subjects [10 (5-15) vs 8 (5-12), P<0.001 and 3 (1-6) vs 2 (1-4), P<0.001, respectively; Fig. 2 ]. The greatest degree of lability was seen in subjects taking ACE/ARBs only, followed by subjects using BB. The least amount of lability was seen in subjects not taking antihypertensive medications (Fig. 2) .
Invasive arterial BP monitoring was used in 29% of patients. These patients had more episodes of lability >10 and >20% [14 (9-20) vs 7 (4-11), P<0.001 and 5 (2-7) vs 2 (1-4), P<0.001, respectively]. Use of invasive BP monitoring, however, did not retain statistical significance in the final models. There was only weak to moderate correlation between the number of episodes of lability >10 or >20% and intraoperative MAP. Lability >10% was most highly correlated with MAP of 70-79 mm Hg (ρ=0.53, P<0.001), suggesting that lability was not strongly influenced by the degree of hypo-or hypertension during surgery.
Effect of intraoperative lability on 30 day mortality
The 30 day mortality for the derivation cohort was 1.22%. Results of the multivariate logistic regression for 30 day mortality are shown in Table 2 . The initial stepwise regression selected lability >10%, MAP <50 mm Hg, and MAP >120 mm Hg as having In the final derivation model, a significant association was found between episodes of lability >10% and decreased mortality in subjects taking no preoperative antihypertensive medication (58.2% of subjects). For each additional episode of lability >10%, the OR for 30 day mortality was 0.95 (95% CI 0.92-0.97), P<0.001.
Analysis of the validation cohort confirmed the association; OR for 30 day mortality was 0.96 ([95% CI 0.93-0.99), P=0.01. The preoperative use of BB or ACE/ARBs appeared to weaken the association ( Table 2) . As the number of episodes of lability increased during the course of a procedure, a progressive protective effect was demonstrated (Fig. 3) . For a subject taking no antihypertensive medications who experienced the median amount of lability >10% (9 episodes), the OR for 30 day mortality was 0.61 (95% CI 0.48-0.79), P<0.001, compared with a subject without any episodes of lability >10%.
There was also a significant association between low intraoperative BP and 30 day mortality in subjects classified as ASA IV or V. For every 5 min period spent with MAP <50 mm Hg, the OR for 30 day mortality was 1.19 (95% CI 1.09-1.29), P<0.001 (Table 2) . Analysis of the validation cohort yielded similar results; OR for 30 day mortality was 1.15 (95% CI 1.04-1.26), P=0.01. This association was also seen in ASA III subjects, although this result was not confirmed in the validation cohort. In contrast, high MAP >120 mm Hg was associated with survival. The OR for 30 day mortality for every 5 min spent with MAP >120 mm Hg was 0.91 (95% CI 0.84-0.99), P=0.03. This effect, however, was not confirmed in the validation cohort. The overall c-statistic for the 30 day mortality model derivation cohort was 0.92, and the P-value for the Hosmer-Lemeshow test was 0.56 ( Table 2 ). The c-statistic and P-value for the validation cohort were similar, both when using β-coefficients derived from the validation cohort and when using β-coefficients derived from the validation cohort itself (Table 2) .
To explore the association between lability >10% and 30 day mortality in hypertensive subjects further without the confounding influence of antihypertensive medication use, we performed a secondary analysis using the subset of subjects from the entire cohort who had documented hypertension without documented antihypertensive use. There were 5997 subjects (11%) in the entire cohort, with 129 deaths, for a 30 day mortality rate of 2.15%. In these subjects, lability >10% was again found to be associated 
Effect of intraoperative lability on perioperative myocardial injury
Non-fatal PMI occurred in 164 of 35 287 patients in the derivation cohort (0.46%). Lability >10% was associated with a statistically significant increase in PMI (Table 3 ). The OR for PMI was 1.05 (95% CI 1.03-1.06), P<0.001 per each additional episode of lability >10%. This result was confirmed in the validation cohort, OR 1.02 (95% CI 1.00-1.05), P=0.03. Mean arterial blood pressure <50 mm Hg was not selected by the initial stepwise logistic regression and was not included from the final model. The overall c-statistic for the PMI model derivation cohort was 0.87, and the P-value for the Hosmer-Lemeshow test was 0.63 (Table 3 ). The c-statistic and P-value for the validation cohort were similar, both when using the β-coefficients derived from the validation cohort and when using β-coefficients derived from the validation cohort itself (Table 3) .
Discussion
In this large retrospective study, we found a clear association between episodes of intraoperative arterial BP lability >10% and a decreased risk of 30 day mortality. The effect was cumulative and increased with each additional episode of lability >10%, such that a patient experiencing the median amount of lability >10% (nine episodes) had a significantly reduced risk of mortality. Furthermore, no association was found between the degree of intraoperative lability and adverse outcome. These findings stand in contrast to the common belief that rapid fluctuations in intraoperative arterial BP are deleterious and that clinicians should strive to maintain 'railroad track' haemodynamics. Labile haemodynamic responses might reflect an intact autonomic nervous system that is adapting appropriately to the stress of surgery. While numerous previous investigations have highlighted the predictive value of preoperative hypertension, baseline intraoperative hypertension, and pulse pressure magnitude with regard to adverse perioperative outcomes, this study is, to our knowledge, the first to explore the dynamic changes in BP over the course of a procedure and to correlate these changes with outcome in a general surgical population. 15 found that hypertensive patients undergoing coronary artery bypass had greater blood pressure variability; however, they were unable to show any association between variability and outcome.
Lability as a protective marker is consistent with the literature demonstrating that autonomic nervous system integrity (as reflected by heart rate variability) is associated with improved outcomes. 21 22 The fact that increased lability is associated with survival suggests that it is an adaptive response that demonstrates physiological reserve. Interestingly, this association became nonsignificant in hypertensive patients taking antihypertensive medications, despite the fact that these patients showed a significant increase in intraoperative BP lability. While these findings seem counterintuitive at first, we believe that the explanation lies in the well-documented effect that many of these drugs have on long-term survival. [23] [24] [25] [26] [27] [28] [29] [30] The protective effect of these medications was probably stronger than the effect of lability. The secondary analysis showing that lability was associated with improved survival in hypertensive patients not taking any antihypertensive medications supports this hypothesis and further reinforces our findings.
The additional finding that intraoperative hypotension is independently associated with mortality in high-risk patients (ASA IV and V) is consistent with other recent investigations. 4 6 31-33 Most recently, Walsh and colleagues 34 found that periods of MAP <55 mm Hg were significantly associated with adverse renal and cardiac outcomes, although they were unable to show a significant association with mortality. The cut-off value of MAP <50 mm Hg identified in our analysis is consistent with these prior studies.
More importantly, our investigation demonstrates a statistically significant association between episodes of low MAP during surgery and postoperative mortality. This suggests that it is important for clinicians to treat low intraoperative BP aggressively, particularly in the highest risk patients. Our data confirm the conventional wisdom shared by many anaesthetists that hypertensive patients exhibit more intraoperative BP lability. The overall difference in the number of episodes of lability was small but significant. In the multivariate model, however, the presence of preoperative hypertension was not found to be associated with increased mortality or PMI. This affirms the results of Howell and colleagues, 18 who, in a large meta-analysis, concluded that the association between pre-existing hypertension and perioperative cardiac risk is likely not to be clinically significant. With regard to our use of pre-induction BP as a baseline, it is important to note, as Howell and colleagues 18 did, that baseline BP in the OR may be elevated as a result of anxiety or 'white coat hypertension', and thus, some patients may appear to be hypertensive by baseline BP when in fact they are not. It is a limitation of our data that we were unable to collect true preoperative (i.e. clinic) BP readings. In the multivariate model, however, an increased baseline BP was found to be protective, not detrimental. Thus, despite the limitation of the initial BP reading as a measure of the true baseline, it is still a clinically relevant measurement. Of further interest is the fact that periods of intraoperative hypertension (MAP >120 mm Hg) did not appear to be detrimental in the perioperative period. Taken altogether, these findings lead us to question the way in which intraoperative haemodynamics are currently managed. Anecdotally, most clinicians strive to maintain non-fluctuating haemodynamics, with MAP values between 60 and 90 mm Hg. Our data suggest that lability should be tolerated, so long as MAP remains above 50 mm Hg.
The proportion of invasive arterial pressure monitoring (28%) is relatively high in this cohort, compared with a general practice hospital. As a tertiary care centre, we perform many complex procedures on a high-risk population. More than 50% of subjects in the entire cohort were ASA physical status III or above, and invasive arterial monitoring was used in more than 40% of these patients. We believe that this proportion is consistent with US practice in similar tertiary care settings. 34 In our preliminary analyses, we explored stratifying the entire patient cohort by invasive vs non-invasive monitoring and found the results to be similar (data not shown). We also explored the interaction between arterial line and lability; again, we found no significant interaction. This is likely to be because use of invasive arterial pressure monitoring is more a marker of complexity of procedure and patient illness than an independent predictor of mortality or lability in its own right. We believe, therefore, that it was appropriate to analyse data from both groups together and that this approach is consistent with other recent investigations. 6 34 The only potential detriment to intraoperative lability was a slightly higher incidence of non-fatal PMI. It is not surprising that imbalances in myocardial oxygen supply and demand that accompany haemodynamic lability would lead to myocardial injury. This finding may or may not be consistent with the results of a large multicentre cohort trial (the VISION Study) that found an association between peak postoperative troponin concentrations and 30 day mortality. 35 36 A key difference between that study and the present investigation is that we explicitly excluded mortalities with elevated troponins from our PMI analysis, because we were primarily interested in investigating the relationship between lability and PMI, and not between PMI and 30 day mortality. Furthermore, the VISION study prospectively measured troponin in all patients, whereas in our study troponins were probably measured only in subjects for whom there was a clinical suspicion of myocardial ischaemia (see 'Limitations' below). It is entirely possible that we would have found an association between PMI and 30 day mortality had we performed that analysis. Certainly, the dichotomous findings merit further investigation.
Limitations
This was a retrospective analysis based on data from a single urban academic medical centre, and as such, may not be generalizable to other populations, and no causality can be implied. As a retrospective study, we cannot determine to what extent the results were affected by the efforts of clinicians to ameliorate BP instability (e.g. administration of i.v. fluid or vasopressors to treat hypotension), or the relationship between episodes of BP lability and other contemporaneous intraoperative events. Although administration of a vasoactive medication might be directly responsible for an episode of lability, we did not validate this assumption. With regard to preoperative medications, the most commonly prescribed antihypertensive medication in our data set was metoprolol. A large percentage of patients take β-blockers for a variety of indications other than hypertension, and we were unable to determine these indications definitively. Regardless of indication, however, β-blockers have an effect on autonomic nervous system reactivity. As they also have an impact upon outcome, we believe that it was appropriate to include them in the analysis. The incidence of PMI in our study population may have been underestimated because troponins were not routinely assessed for all patients. However, our use of serum troponin concentrations as a marker of myocardial injury and the rate of PMI seen in our data set are validated by several recent large investigations. 35 37 38 Additionally, we were unable to examine the relationship between intraoperative BP lability and perioperative stroke, owing to a relatively low incidence and lack of sufficient data in the medical records (e.g. inability to determine the timing and nature of any perioperative cerebrovascular events). This is an important outcome that might be affected by frequent changes in BP during surgery.
Statistical limitations
There are potentially alternative statistical approaches that we could have used in our analysis. Some statisticians believe that using a bootstrapping technique is a more modern and valid approach than using a split cohort. Bootstrap validation is able to provide an estimate of the prediction error, which is not possible with a simple split cohort. Data splitting also suffers from a reliability problem unless the sample size is large enough. Nevertheless, it has advantages of allowing hypothesis tests to be confirmed in the test samples in a straightforward manner. Given the size of our study sample, we believe that our results would have been very similar if we had used alternative statistical methods, such as bootstrapping. The analysis of haemodynamic lability is complicated by the absence of any gold standards for grading its severity. We believe that deriving lability thresholds using a stepwise logistical regression approach was the most appropriate method to demonstrate the natural point at which outcome effects became evident.
Conclusion
In conclusion, intraoperative blood pressure variability has relevance to outcome, controlling for patient and surgical risk factors. Contrary to common perception, however, BP lability is not harmful, but is rather a positive prognostic indicator in the majority of patients undergoing anaesthesia and surgery.
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